Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Aprea Therapeutics, Inc. (APRE) had Income from Continuous Operations of $-3.59M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-3.59M |
|
-- |
|
-- |
|
$4.03M |
|
$-4.03M |
|
$0.44M |
|
$-3.59M |
|
$-3.59M |
|
$-3.59M |
|
|
Income from Continuous Operations |
$-3.59M |
$-3.59M |
|
$-3.59M |
|
$-4.03M |
|
$-4.03M |
|
53.48M |
|
53.48M |
|
$-0.07 |
|
$-0.07 |
|
| Balance Sheet Financials | |
$41.91M |
|
$0.06M |
|
$0.38M |
|
$42.29M |
|
$3.09M |
|
-- |
|
$0.73M |
|
$3.82M |
|
$38.47M |
|
$38.47M |
|
$38.47M |
|
12.39M |
|
| Cash Flow Statement Financials | |
$-6.04M |
|
$-0.02M |
|
$32.69M |
|
$14.64M |
|
$41.27M |
|
$26.63M |
|
$0.20M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.55 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.05M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-9.34% |
|
-9.34% |
|
-8.49% |
|
-9.34% |
|
$3.10 |
|
$-0.11 |
|
$-0.11 |
|